UBM India Gears up to Host Biggest India Pharma Awards Night

As the pharmaceutical industry is increasingly looking towards India for higher quality, low cost pharmaceutical solutions, the UBM India Pharma Awards is the perfect place for companies to engage with the movers and shakers in India's pharmaceutical machinery, technology, ingredients, outsourcing and biopharma industry. India Pharma Awards 2015, this year, covers a wide range of activities of the India pharmaceutical sector through 13 different nomination-based categories and four different jury-based categories.

Nomination Based Categories include:

• Operational Excellence Excellence in Environment, Health & Safety


• Excellence in Supply Chain Management Excellence in IT Automation (IT Vendors)


• Excellence in Pharmaceutical


• Machinery/Instruments Excellence in Rural Reach


• Excellence in Packaging Development Excellence in Business Performance


• Excellence in Contract Research Excellence in R & D


• Excellence in Corporate Social


• Responsibility Excellence in Brand / Product


• Excellence in Export Promotion
  
  Jury Based Categories include:


• Emerging Entrepreneur of the Year Woman Pharma Personality of the Year


• Lifetime Achievement Award Inspirational Leader Award

The expert jury panel comprises of eminent names from the industry, bringing in a wide canvas of experience - Dr. Ajit Dangi, President & CEO, Danssen Consulting; S V Veerramani, President, Indian Drug Manufacturers' Association; Divesh Kumar Singla, Director & Global Lead, Global Market Insights Analyst Services; Mr. B G Barve, Joint Managing Director, Blue Cross Laboratories; Mr. S Srinivasan, Managing Director, Shriram Industrial Holdings; and Mr. S M Mudda, Director - Global Strategy (Technical), Micro Labs Limited.

India Pharma Awards 2015 will also witness the launch of two Collector's Edition Publications - The World of P-MEC - Collector's Edition (From P-MEC point of view) and India Pharma Exporters - Collector's Edition (From CPhI & Pharma Exporters Point of View), which will be distributed at CPhi P-MEC in various formats like CDs, pen drives, hard copies and will be published online as well. These publications will reach out to 1,00,000+ CPhI P-MEC visitors and exhibitors globally along with leading banks, VCs, embassies, etc. The publication will feature exclusive content comprising of insights, research-based analysis, future trends and opportunities for the sector, listing and profiling of leading pharmaceutical companies in their respective space.